(Q33561919)

English

Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Seth M Steinberg

5

object named as

Seth M Steinberg

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Douglas L. Fraker

2

object named as

Douglas L Fraker

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

H. Richard Alexander

1

object named as

H Richard Alexander

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

David L Bartlett

3

object named as

David L Bartlett

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

object named as

Steven K Libutti

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Perry Soriano

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Tatiana Beresnev

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

9 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

114-118

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

21 June 2018

TNF dose reduction in isolated limb perfusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

21 June 2018

Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

21 June 2018

Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

21 June 2018

Effects of isolated limb perfusion with tumour necrosis factor-alpha on the function of monocytes and T lymphocytes in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

21 June 2018

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

21 June 2018

Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

31 October 2018

Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799229

31 October 2018

Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of p-[di(2-chloroethyl)]-amino-l-phenylalanine on Harding-Passey mouse melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2009.23.7511

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33561919&oldid=1999655135"